Pharmafile Logo
Pharmafocus logo
Advanced Search

John Lechleiter

Showing 5 posts of 5 posts found.

johnnolech

John Lechleiter to step down as Lilly CEO

July 27, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, John Lechleiter

Eli Lilly has announced that CEO John Lechleiter is set to retire, with David Ricks to assume the role as …

News
lechleiter_john_300dpi

Lilly’s John Lechleiter elected as PhRMA Board chairman

April 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, John Lechleiter, Pfizer, Sanofi, lilly

John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …

Appointment

Lilly chief: German reforms jeopardise pharma innovation

July 8, 2011
Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing

German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …

News

Smelly Risperdal adds to J&J’s recall tally

June 20, 2011
Manufacturing and Production John Lechleiter, pharma manufacturing news, recalls

Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug …

News
Eli Lilly chief executive John Lechleiter

Lilly chief issues warning on UK reforms

February 11, 2011
Research and Development, Sales and Marketing John Lechleiter, US health reforms, healthcare reform, lilly, patent box, value-based pricing

Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025